Related Experiment Video
Updated: Oct 16, 2025

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
Emerging role of let-7 family in the pathogenesis of hematological malignancies
Fatemeh Yazarlou1, Sepideh Kadkhoda1, Soudeh Ghafouri-Fard2
1Department of Medical Genetics, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:
Let-7 includes a family of miRNA which are implicated in the developmental processes as well as carcinogenesis. This miRNA family has been shown to influence pathogenesis of a variety of hematological malignancies through changing expression of a number of oncogenic pathways, particularly those related with MYC. Expression of these miRNAs has been found to be different between distinct hematological malignancies or even between cytogenetically-defined subgroups of a certain malignancy. In the current review, we summarize the data regarding biogenesis, genomic locations, targets and regulatory network of this miRNA family in the context of hematological malignancies.
Insights
The let-7 microRNA family plays a role in cancer development and hematological malignancies by regulating oncogenic pathways like MYC. Their expression varies across different blood cancers, influencing disease progression.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Let-7 microRNAs (miRNAs) are crucial regulators in development and carcinogenesis.
- This miRNA family influences hematological malignancies by modulating oncogenic pathways, notably those involving MYC.
- Differential expression of let-7 miRNAs is observed across various hematological malignancies and their subgroups.
Purpose of the Study:
- To review the biogenesis of let-7 miRNAs.
- To summarize genomic locations, targets, and regulatory networks of let-7 miRNAs in hematological malignancies.
- To provide a comprehensive overview of let-7 miRNA involvement in blood cancers.
Main Methods:
- Literature review of existing studies on let-7 miRNAs.
- Analysis of data on miRNA expression in hematological malignancies.
- Synthesis of information on miRNA biogenesis, targets, and regulatory networks.
Main Results:
- Let-7 miRNAs are implicated in both normal development and cancer formation.
- Dysregulation of let-7 miRNAs impacts the pathogenesis of hematological malignancies.
- Expression patterns of let-7 miRNAs differ significantly among hematological cancer types and subtypes.
Conclusions:
- The let-7 miRNA family is a significant factor in hematological malignancies.
- Understanding let-7 miRNA networks is crucial for deciphering blood cancer biology.
- Further research into let-7 miRNAs may reveal novel therapeutic targets for hematological cancers.
More Related Videos
12:44Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis
Published on: November 11, 2014
11:40Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
Published on: October 20, 2014
Related Concept Videos
MicroRNAs
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Regulation of Hematopoietic Stem Cells
Lineage Commitment
lncRNA - Long Non-coding RNAs
Differentiation of Common Myeloid Progenitor Cells